What are the guidelines on ovarian cancer screening in the general population?

Updated: Aug 10, 2020
  • Author: Andrew E Green, MD; Chief Editor: Yukio Sonoda, MD  more...
  • Print


The US Preventive Services Task Force (USPSTF) recommends against screening (with serum CA-125 level or transvaginal ultrasonography) for ovarian cancer in the general population. [3] The US Food & Drug Administration (FDA) recommends against the use of tests marketed for ovarian cancer screening. [4] The National Cancer Institute (NCI) cites evidence of lack of mortality benefit with screening, and potential harms relating to false-positive test results. [5]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!